Prad Sekar on Leveraging Data to Bring Medical Cannabis to the Masses

CB2 Insight's (CSE:CBII) CEO Pradyum Sekar recently sat down with Barrington Miller to discuss the importance of medically validated cannabis data (3:45), the challenge of breaking down barriers with physicians (9:45), and the impact of big pharma on medical cannabis (13:30). Listen until the end to hear about Prad's experience around launching the company, pivoting the business (hint - vertical integration!), and their recent launch on the CSE - Canadian Securities Exchange.